Alteogen Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW789 |
Market Cap |
KRW431.13 B |
Shares Outstanding |
12.64 M |
Public Float |
7.82 M |
Address |
62 Yuseong-daero 1628beon-gil Daejeon DE 34054 Korea, Republic Of |
Employees | - |
Website | http://www.alteogen.com |
Updated | 09/14/2018 |
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea. |